Cargando…
Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients
Background: The aim of this study was to investigate the efficacy of post-neoadjuvant chemotherapy (NAC) ultrasound (US), magnetic resonance imaging (MRI), and F-18fluorodeoxyglucose positron emission tomography (F-18 FDG-PET/CT) for detecting post-NAC axillary lymph node(ALN) metastasis in patients...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700016/ https://www.ncbi.nlm.nih.gov/pubmed/34943597 http://dx.doi.org/10.3390/diagnostics11122361 |
_version_ | 1784620654117519360 |
---|---|
author | Turan, Umit Aygun, Murat Duman, Berna Bozkurt Kelle, Aygül Polat Cavus, Yeliz Tas, Zeynel Abidin Dirim, Ahmet Baris Irkorucu, Oktay |
author_facet | Turan, Umit Aygun, Murat Duman, Berna Bozkurt Kelle, Aygül Polat Cavus, Yeliz Tas, Zeynel Abidin Dirim, Ahmet Baris Irkorucu, Oktay |
author_sort | Turan, Umit |
collection | PubMed |
description | Background: The aim of this study was to investigate the efficacy of post-neoadjuvant chemotherapy (NAC) ultrasound (US), magnetic resonance imaging (MRI), and F-18fluorodeoxyglucose positron emission tomography (F-18 FDG-PET/CT) for detecting post-NAC axillary lymph node(ALN) metastasis in patients who had ALN metastasis at the time of diagnosis. Methods: This study included all breast cancer patients who received NAC for ALN metastasis; underwent axillary assessment with US, MRI, or F18FDG-PET/CT; and then were operated on in the General Surgery Clinic, Adana City Research and Training Hospital, Turkey. Patients’ data were recorded, including demographic data, clinicopathological parameters, NAC regimens, and operation types. The axillary response to chemotherapy on post-NAC US, MRI, and F-18 FDG-PET/CT was compared with the postoperative histopathological result of the ALN. Results: The study included a total of 171 female patients. The mean age of the patients was 53.28 ± 10.62 years. The post-NAC assessment revealed that the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of US for detecting ALN metastasis were 59.42%, 82.35%, 82.00%, and 60.00%, respectively, while the same measures regarding MRI for detecting ALN metastasis were 36.67%, 77.78%, 73.33%, and 42.42%, respectively. The sensitivity, specificity, PPV, and NPV of F-18FDG-PET/CT were 47.50%, 76.67%, 73.08%, and 52.27%, respectively. The evaluation of dual combinations of these three imaging techniques showed that the specificity and PPV of the combined use of US and F-18FDG-PET/CT was 100%. Conclusions: The results showed that US has the highest sensitivity and specificity for detecting ALN metastasis after NAC. Furthermore, ALND may be preferred for these patients instead of SLNB if both examinations simultaneously indicate lymph node metastasis in the post-NAC assessment with US and F-18 FDG-PET/CT. SLNB may be preferred if these two examinations simultaneously show a complete response. |
format | Online Article Text |
id | pubmed-8700016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87000162021-12-24 Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients Turan, Umit Aygun, Murat Duman, Berna Bozkurt Kelle, Aygül Polat Cavus, Yeliz Tas, Zeynel Abidin Dirim, Ahmet Baris Irkorucu, Oktay Diagnostics (Basel) Article Background: The aim of this study was to investigate the efficacy of post-neoadjuvant chemotherapy (NAC) ultrasound (US), magnetic resonance imaging (MRI), and F-18fluorodeoxyglucose positron emission tomography (F-18 FDG-PET/CT) for detecting post-NAC axillary lymph node(ALN) metastasis in patients who had ALN metastasis at the time of diagnosis. Methods: This study included all breast cancer patients who received NAC for ALN metastasis; underwent axillary assessment with US, MRI, or F18FDG-PET/CT; and then were operated on in the General Surgery Clinic, Adana City Research and Training Hospital, Turkey. Patients’ data were recorded, including demographic data, clinicopathological parameters, NAC regimens, and operation types. The axillary response to chemotherapy on post-NAC US, MRI, and F-18 FDG-PET/CT was compared with the postoperative histopathological result of the ALN. Results: The study included a total of 171 female patients. The mean age of the patients was 53.28 ± 10.62 years. The post-NAC assessment revealed that the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of US for detecting ALN metastasis were 59.42%, 82.35%, 82.00%, and 60.00%, respectively, while the same measures regarding MRI for detecting ALN metastasis were 36.67%, 77.78%, 73.33%, and 42.42%, respectively. The sensitivity, specificity, PPV, and NPV of F-18FDG-PET/CT were 47.50%, 76.67%, 73.08%, and 52.27%, respectively. The evaluation of dual combinations of these three imaging techniques showed that the specificity and PPV of the combined use of US and F-18FDG-PET/CT was 100%. Conclusions: The results showed that US has the highest sensitivity and specificity for detecting ALN metastasis after NAC. Furthermore, ALND may be preferred for these patients instead of SLNB if both examinations simultaneously indicate lymph node metastasis in the post-NAC assessment with US and F-18 FDG-PET/CT. SLNB may be preferred if these two examinations simultaneously show a complete response. MDPI 2021-12-14 /pmc/articles/PMC8700016/ /pubmed/34943597 http://dx.doi.org/10.3390/diagnostics11122361 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Turan, Umit Aygun, Murat Duman, Berna Bozkurt Kelle, Aygül Polat Cavus, Yeliz Tas, Zeynel Abidin Dirim, Ahmet Baris Irkorucu, Oktay Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients |
title | Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients |
title_full | Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients |
title_fullStr | Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients |
title_full_unstemmed | Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients |
title_short | Efficacy of US, MRI, and F-18 FDG-PET/CT for Detecting Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Breast Cancer Patients |
title_sort | efficacy of us, mri, and f-18 fdg-pet/ct for detecting axillary lymph node metastasis after neoadjuvant chemotherapy in breast cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700016/ https://www.ncbi.nlm.nih.gov/pubmed/34943597 http://dx.doi.org/10.3390/diagnostics11122361 |
work_keys_str_mv | AT turanumit efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients AT aygunmurat efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients AT dumanbernabozkurt efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients AT kelleaygulpolat efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients AT cavusyeliz efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients AT taszeynelabidin efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients AT dirimahmetbaris efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients AT irkorucuoktay efficacyofusmriandf18fdgpetctfordetectingaxillarylymphnodemetastasisafterneoadjuvantchemotherapyinbreastcancerpatients |